Navigation Links
SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
Date:11/7/2007

ent of atherothrombotic events in patients with acute coronary syndrome and in those with prior myocardial infarction or stroke, as well as in patients with existing peripheral arterial disease.

The U.S. Food and Drug Administration (FDA) had previously granted Fast Track designation to the compound. Fast Track designation allows FDA to expedite review of drugs and biologics for serious or life-threatening conditions which demonstrate the potential to address unmet medical needs.

Thrombosis may result in partial or complete blockage of arteries in the heart, brain or periphery. This process is the underlying mechanism of most acute vascular events, including acute coronary syndromes (ACS), such as myocardial infarction (MI), and ischemic stroke, which are the leading causes of death. Platelets are activated at the site of atherosclerotic plaque rupture in arteries and release substances that initiate aggregation and clot formation, and thrombin is the most potent activator of platelets. Drugs that block platelet activation by other mechanisms, such as the thromboxane- or ADP-mediated pathways, have shown reduction in such clinical events, but events continue to occur despite these therapies. There is, thus, a need for novel agents that specifically modify the actions of thrombin, the most potent activator of platelets.

TRA binds selectively to the thrombin receptor on platelets (PAR-1), and is therefore a member of a potentially new class of drugs called thrombin receptor antagonists.

Importantly, Schering-Plough's TRA is being investigated to determine whether it has the potential to provide clinical benefit through inhibition of this thrombin-mediated platelet activation without the liability of increased bleeding (when added to standard of care), a tendency associated with drugs that block thromboxane or ADP pathways. Specifically, this compound is being investigated as an oral antiplatelet agent for patients with established vascular dise
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... August 22, 2014 ... the addition of the  "Global Operating Room ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,An ... sterile environment in a healthcare facility used ... with technically advanced equipment, which ensures patient ...
(Date:8/22/2014)... HILL, N.C. , Aug. 22, 2014  As ... the healthcare sector, many leaders in this area are ... The Medical Affairs Consortium at Best ... a forum for sharing insights about the key challenges ... creating and sharing solutions through three virtual roundtable discussions ...
(Date:8/22/2014)...  Dr. Mark Rasak , MD is recognized ... Award in the field of Medicine as a result ... Dr. Rasak has over 15 years of ... the business; overseeing the daily operations; interventional cardiology; complex ... addition, he is an honored Fellow of the American ...
Breaking Medicine Technology:Global Operating Room Equipment Market 2014-2018: Key Vendors are Getinge, STERIS, Stykron and TRUMPF Medical Systems 2Best Practices' Medical Affairs Consortium Survey Has Achieved Strong Participation 2Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2
... DALLAS, October 28, 2011   ... Analysis and Forecasts to 2020, to its store. This ... US. In addition, it covers detailed clinical assessment of ... analysis of sales performance during the forecast period (2016-2020). ...
... Publicis Groupe announced today that Digitas Health and ... (PHCG), powerfully redefining Publicis Groupe,s client offering to ... PHCG is the world,s leading healthcare communications ... Razorfish Health -- Publicis Groupe,s largest digital agencies ...
Cached Medicine Technology:ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020 2ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020 3ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020 4Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 2Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 3Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 4Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 5
(Date:8/22/2014)... 2014 Advancements in ultrasound technologies ... applications due to their cost-effectiveness, non-invasiveness, and absence ... ultrasound, such as the evolution of wireless transducers ... the market moving throughout 2014 and beyond. Such ... not only the point-of-care (POC) testing in hospital ...
(Date:8/22/2014)... Eagerly embracing intended parents around the globe, ... offers the top male infertility programs — run by ... network of IVFinMexico.com continues to shape modern ... female and male infertility, advanced research and education. , ... eminently set by company CEO and Founder Tolga Umar ...
(Date:8/22/2014)... August 22, 2014 CarePoint Health ... in Internal Medicine, Geriatrics, Hospice and Palliative Care, ... Health Medical Group. Their system welcomes Dr. Reisner ... experienced physicians comprise CarePoint Health Medical Group, a ... Hudson County, representing a wide range of specialties. ...
(Date:8/22/2014)... An intensive effort to sterilize feral cats reduced the number ... euthanized, a new study reveals. "We investigated whether we ... animal control," Dr. Julie Levy, a professor of shelter medicine ... in a university news release. "Neutering a few ... explained, "so we wanted to pick a focused area and ...
(Date:8/22/2014)... 22, 2014. A new study of self-awareness ... multiple sclerosis (MS) may be able to improve ... was epublished ahead of print on July 2 ... Hali Griswold, Nancy D. Chiaravalloti & John DeLuca: ... multiple sclerosis doi: 10.3233/NRE-141113). Self-awareness is one,s ability ...
Breaking Medicine News(10 mins):Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4Health News:Dr. Reisner Joins CarePoint Health Medical Group 2Health News:Neutering Project Curbed Feral Cat Population 2Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2
... as ,Natural, and ,Organic, Should Still Have Cancer Warning , ... Friday, March 6, 2009 a follow-up study on 1,4-dioxane contamination ... (OCA) , a watchdog group with over 500,000 members, and ... (author of The Safe Shopper,s Bible ), ...
... Public Policy & Aging Report (PPAR) ... These include deductions, exemptions, deferrals, and circuit breakers, most ... particular relevance as President Barack Obama prepares a plan ... and older who earn less than $50,000. , "In ...
... 27 Orthopaedic surgeon Thomas C. Barber, MD, was ... (BOC)( http://www3.aaos.org/member/bdcounc/bocinfo.cfm ) of the American Academy ... the 2009 Annual Meeting at the Venetian Sands Expo ... on the Academy,s Board of Directors. The BOC ...
... VEGAS, Feb. 27 Orthopaedic surgeon David Polly ... Societies (BOS), of the American Academy of Orthopaedic Surgeons ... Dr. Polly will also sit on the Academy,s Board ... the Department of Orthopaedic Surgery at the University of ...
... BIRMINGHAM, Ala., Feb. 27 HealthSouth Corporation (NYSE: ... released by the Office of Management and Budget on February ... HealthSouth has been a leader in advocating ... care system and the inefficiencies created by those barriers, so ...
... Celebrities and Hollywood elite celebrated the launch of ... Biomedical Skin Treatments ... Garth Fisher and beauty industry veteran Paul Scott ... in the heart of Los Angeles. (Photo: ...
Cached Medicine News:Health News:Follow-Up Tests of Leading Personal Care and Household Cleaning Brands Reveal Significant Improvements in Levels of Carcinogenic 1,4-dioxane 2Health News:Thomas C. Barber, MD, Elected Chair of Academy Board of Councilors 2Health News:Thomas C. Barber, MD, Elected Chair of Academy Board of Councilors 3Health News:David W. Polly Jr., MD, Elected Secretary of Academy Board of Specialty Societies 2Health News:HealthSouth Issues Preliminary Comments on the President's Healthcare Budget Proposal and Announces Plans to Host a Conference Call 2Health News:Kim Kardashian and Tia Carrere Celebrate Premiere of Revolutionary CellCeuticals(R) Biomedical Skin Treatments at Social Hollywood with Founders Dr. Garth Fisher and Paul Scott Premo 2Health News:Kim Kardashian and Tia Carrere Celebrate Premiere of Revolutionary CellCeuticals(R) Biomedical Skin Treatments at Social Hollywood with Founders Dr. Garth Fisher and Paul Scott Premo 3
... Hema-G Stains for Geometric Data ... performance. Stains are quality control ... to ensure proper staining and ... most applications for a minimum ...
Wright Stain Solutions...
... single-solution staining, Hema-Quik for Wright ... stain solution for five to ... water for five to fifteen ... by dipping quickly in deionized ...
This stain is the McNeal formula and can be substituted for Wright Stain solution....
Medicine Products: